Virtu Financial’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,107
Closed -$43K 2328
2023
Q4
$43K Buy
+12,107
New +$50.9K ﹤0.01% 1202
2022
Q2
Sell
-2,335
Closed -$78K 2216
2022
Q1
$78K Buy
+2,335
New +$83K 0.01% 1030
2021
Q4
Sell
-2,921
Closed -$237K 2294
2021
Q3
$237K Buy
2,921
+1,357
+87% +$121K 0.02% 831
2021
Q2
$43K Buy
+1,564
New +$40.1K ﹤0.01% 1354
2021
Q1
Sell
-5,032
Closed -$127K 2150
2020
Q4
$127K Buy
+5,032
New +$82.6K 0.01% 999
2018
Q3
Sell
-437
Closed -$46K 2346
2018
Q2
$46K Sell
437
-216
-33% -$23.8K ﹤0.01% 1773
2018
Q1
$74K Buy
653
+380
+139% +$47.6K ﹤0.01% 1639
2017
Q4
$38K Buy
+273
New +$39.2K ﹤0.01% 2122

Other funds holding NURO

Virtu Financial's NURO Position: Q1 2024 in Review

Virtu Financial sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q1 2024, closing a stake of 12,107 shares — an estimated $43K sold.

Virtu Financial first reported a position in NURO in Q4 2017 and held it in 8 quarters. The position peaked at $237K in Q3 2021. 12 funds tracked by Wall St. Rank hold NURO as of Q1 2024.

  • Virtu Financial reported no remaining NeuroMetrix, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 12,107 NeuroMetrix, Inc. Common Stock shares in Q1 2024, an estimated $43K.
  • Virtu Financial first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
  • Virtu Financial's NeuroMetrix, Inc. Common Stock position peaked at $237K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.